We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

FDA Shakes Head At Stryker's Plant Practices

Law360 (January 16, 2008, 12:00 AM EST) -- The U.S. Food and Drug Administration has warned Stryker Orthopedics Corp. that it may face regulatory action if it does not correct quality control issues with its joint replacement devices.

In a warning letter sent to Stryker CEO Steven MacMillan, which was posted on the FDA’s Web site on Tuesday, the agency accused the company of failing to meet federal regulations requiring procedures that avoid nonconformities, ensure consistency and control environmental conditions during the manufacture of medical devices.

After inspecting Stryker's Mahwah, N.J., plant between June...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.